T cell malignancies trang 1 tải miễn phí từ tailieunhanh

"T cell malignancies" trang 1 - tải miễn phí từ tailieunhanh

$The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies: A meta-analysis$

The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies: A meta-analysis

13 33 1

CD26 Expression on T-Anaplastic Large Cell Lymphoma (ALCL) Line Karpas 299 is associated with increased expression of Versican and MT1-MMP and enhanced adhesion

CD26 Expression on T-Anaplastic Large Cell Lymphoma (ALCL) Line Karpas 299 is associated with increased expression of Versican and MT1-MMP and enhanced adhesion

11 54 1

Distribution of chimeric antigen receptormodified T cells against CD19 in B-cell malignancies

Distribution of chimeric antigen receptormodified T cells against CD19 in B-cell malignancies

10 35 1

$Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed/refractory hematological malignancies after CAR-T cell therapy$

Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed/refractory hematological malignancies after CAR-T cell therapy

8 8 1

PLZF overexpression in T-ALL cell line CEM-C7H2-2C8 downregulates glucocorticoid receptor (GR) and its target genes

PLZF overexpression in T-ALL cell line CEM-C7H2-2C8 downregulates glucocorticoid receptor (GR) and its target genes

4 85 0

Recent progress in improving the safety and efficacy of chimeric antigen receptor T cell therapy

Recent progress in improving the safety and efficacy of chimeric antigen receptor T cell therapy

10 52 0